Sex-based differences in cardiac arrhythmias, ICD utilisation and cardiac resynchronisation therapy

Netherlands Heart Journal

Volumn 19, Issue 1, 2011, Pages 35-40

  Ghani, A ^a   Maas, A H E M ^a   Delnoy, P P H M ^a   Ramdat Misier, A R ^a   Ottervanger, J P ^a   Elvan, A ^a  

^a Isala Klinieken ^*  (Netherlands)

Author keywords

Gender differences; ICR or CRT; Pregnancy; Supraventricular tachycardia; Treatment; Ventricular tachycardia

Indexed keywords

ANTIARRHYTHMIC AGENT; FLECAINIDE; QUINIDINE; SOTALOL;

ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; BRUGADA SYNDROME; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; DISEASE SEVERITY; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART RATE VARIABILITY; HUMAN; LONG QT SYNDROME; MENSTRUAL CYCLE; OUTCOME ASSESSMENT; QRS COMPLEX; QT INTERVAL; REVIEW; RISK BENEFIT ANALYSIS; SEX DIFFERENCE; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA;

EID: 79955451110     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12471-010-0050-8     Document Type: Review

References (36)

1. Bazett HC. An analysis of the time-relations of electrocardiogram. Heart. 1920;7:353-70.
2. Liu K, Ballew C, Jacobs Jr DR, Sidney S, Savage PJ, Dyer A, et al. Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study. Hypertension. 1989;14:218-26.
3. Larsen JA, Kadish AH. Effects of gender on cardiac arrhythmia. J Cardiovasc Electrophysiol. 1998;9:655-64.
4. Bernal O, Moro C. Cardiac arrhythmias in women. Rev Esp Cardiol. 2006;59:609-18.
5. Josephson ME, Kastor JA. Supraventricular tachycardia: mechanisms and management. Ann Intern Med. 1977;87:346-58.
6. Insulander P, Kenneback G, Straat E. Differences in dual AV nodal properties between men and women. Eur Heart J. 1999;20:568. abstract.
7. Yarnoz MJ, Curtis AB. More reasons why men and women are not the same (gender differences in electrophysiology and arrhythmias). Am J Cardiol. 2008;101:1291-6.
8. Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Lévy S, Cobbe S, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol. 2007;49:572-7.
9. Essebag V, Reynolds MR, Hadjis T, Lemery R, Olshansky B, Buxton AE, et al. Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med. 2007;167:1648-53.
10. Burke JH, Ehlert FA, Kruse JT, Parker MA, Goldberger JJ, Kadish AH. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol. 1997;79:178-81.
11. Elkayam M, Goodwin TM. Adenosine therapy for supraventricular tachycardia during pregnancy. Am J Cardiol. 1995;75:521-3.
12. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular tachycardia. J Am Coll Cardiol. 2003;42:1493-531.
13. Nakagawa M, Katou S, Ichinose M, Nobe S, Yonemochi H, Miyakawa I, et al. Characteristics of new-onset ventricular arrhythmias in pregnancy. J Electrocardiol. 2004;37:47-53.
14. Marchlinski FE, Deely MP, Zado ES. Sex-specific triggers for right ventricular outflow tract tachycardia. Am Heart J. 2000;139:1009-13.
15. Rivero A, Curtis AB. Sex differences in arrhythmias. Curr Opin Cardiol. 2010;25:8-15.
16. Sacher F, Meregalli P, Veltmann C, Field ME, Solnon A, Bru P, et al. Are women with severely symptomatic brugada syndrome different from men? J Cardiovasc Electrophysiol. 2008;19:1181-5.
17. Jongman JK, Jepkes-Bruin N, Ramdat Misier AR, Beukema WP, Delnoy PP, Oude Lutttikhuis H, et al. Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally. Neth Heart J. 2007;15:151-5.
18. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, et al. Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocar- dial infarction and left ventricular dysfunction, heart failure or both. N Engl J Med. 2005;352:2581-8.
19. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States 1989 to1998. Circulation. 2001;104:2158-63.
20. Chugh SS, Uy-Evanado A, Teodorescu C, Reinier K, Mariani R, Gunson K, et al. Women have a lower prevalence of structural heart disease as a precursor to sudden cardiac arrest: the Ore- SUDS (Oregon Sudden Unexpected Death Study). J Am Coll Cardiol. 2009;54:2006-11.
21. Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global use of strategies to open occluded coronary arteries in acute coronary syndromes IIb investigators. N Engl J Med. 1999;341:226-32.
22. Freedman RA, Swerdlow CD, Soderholm-Difatte V, Mason JW. Clinical predictors of arrhythmia inducibility in survivors of cardiac arrest: importance of gender and prior myocardial infarction. J Am Coll Cardiol. 1988;12:973-8.
23. Buxton AE, Hafley GE, Lehmann MH, Gold M, O'Toole M, Tang A, et al. Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease. Utility of clinical variables. Circulation. 1999;99:1843-50.
24. Davis DR, Tang AS, Lemery R, Green MS, Gollob MH, Birnie DH. Influence of gender on ICD implantation for primary and secondary prevention of sudden cardiac death. Europace. 2006;8:1054-6.
25. Russo AM, Day JD, Stolen K, Mullin CM, Doraiswamy V, Lerew DL, et al. Implantable cardioverter defibrillators: do women fare worse than men? Gender comparison in the INTRINSIC RV trial. J Cardiovasc Electrophysiol. 2009;20:973-8.
26. Chen HA, Hsia HH, Vagelos R, Fowler M, Wang P, Al-Ahmad A. The effect of gender on mortalityor appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter- defibrillators. Pacing Clin Electrophysiol. 2007;30:390-4.
27. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med. 1996;335:1933-40.
28. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-53.
29. Stellbrink C, Breithardt OA, Franke A, Sack S, Bakker P, Auricchio A, et al. PATCH-CHF investigators. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conducton disturbances. J Am Coll Cardiol. 2001;38:1957-65.
30. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al. Multisite Stimulation in Cardiomyopathies (MUSTIC) study investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873-80.
31. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. MADIT-CRT trial investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329-38.
32. Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda Jr JA, Curtis AB. Ventricular reverse remodeling and 6-months outcomes in patients receiving cardiac resynchronization therapy: analysis of MIRACLE study. J Interv Card Electrophysiol. 2005; 12:107-13.
33. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-50.
34. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchroni- zation on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-49.
35. Zardkoohi O, Nandigam V, Murray L, Heist EK, Mela T, Orencole M, et al. The impact of age and gender on cardiac resynchronization therapy outcome. Pacing Clin Electrophysiol. 2007;30:1344-8.
36. Bleeker GB, Schalij MJ, Boersma E, Steendijk P, van der Wall EE, Bax JJ. Does a gender difference in response to cardiac resynchronization therapy exist? Pacing Clin Electrophysiol. 2005;28:1271-5.